These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 39043379)

  • 1. Surgical resection versus thermal ablation after intra-arterial conversion therapy for unresectable hepatocellular carcinoma: a multicenter retrospective one as per the STROBE guidelines.
    Du Y; An C; Liu W
    Int J Hyperthermia; 2024; 41(1):2380001. PubMed ID: 39043379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study.
    Li B; Wang C; He W; Qiu J; Zheng Y; Zou R; Lin Z; Shi Y; Yuan Y; Zhang R; Zhang C; Chen M; Lau WY; Yuan Y
    Int J Surg; 2024 May; 110(5):2545-2555. PubMed ID: 38329081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study.
    Wu JY; Wu JY; Fu YK; Ou XY; Li SQ; Zhang ZB; Zhou JY; Li B; Wang SJ; Chen YF; Yan ML
    Ann Surg Oncol; 2024 May; 31(5):3073-3083. PubMed ID: 38316732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
    Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
    J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
    BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
    Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Therapy of Transcatheter Arterial Chemoembolization and Radiofrequency Ablation versus Surgical Resection for Single 2-3 cm Hepatocellular Carcinoma: A Propensity-Score Matching Analysis.
    Lee HJ; Kim JW; Hur YH; Shin SS; Heo SH; Cho SB; Kang YJ; Lim HS; Seon HJ; Jeong YY
    J Vasc Interv Radiol; 2017 Sep; 28(9):1240-1247.e3. PubMed ID: 28688816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave ablation versus surgical resection for subcapsular hepatocellular carcinoma: a propensity score-matched study of long-term therapeutic outcomes.
    Liu K; Zheng H; Sui X; Liu B; Meng M; Feng Y; Zhu Q; Zhao X
    Eur Radiol; 2023 Mar; 33(3):1938-1948. PubMed ID: 36114849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal ablation versus surgical resection for localized hepatocellular carcinoma: a population study using the SEER database.
    Mills A; Thayer D; Noda C; Salter A; Tao Y; Xing M; Martin R; Ramaswamy R; Akinwande O
    Future Oncol; 2018 Mar; 14(7):631-645. PubMed ID: 29517284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermal Ablation Versus Stereotactic Body Radiotherapy After Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.
    Nabavizadeh N; Jahangiri Y; Rahmani R; Tomozawa Y; Geeratikun Y; Chen Y; Hung A; Degnin C; Farsad K
    AJR Am J Roentgenol; 2021 Sep; 217(3):691-698. PubMed ID: 32997517
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparing Long-Term survival benefits of hepatocellular carcinoma between thermal ablation monotherapy and combined therapy with transarterial Chemoembolization: A propensity score matched study.
    Zhang K; Mu L; Ren Y; Jiang T
    Eur J Radiol; 2023 Oct; 167():111092. PubMed ID: 37708678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness.
    Huang T; Qi H; Shen L; Wu Y; Song Z; Cao F; Liu Y; Xie L; Chen S; Tang T; Li H; Zhang Y; Feng L; Zhang H; Chen J; Fan W
    Int J Hyperthermia; 2022; 39(1):935-945. PubMed ID: 35853727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
    Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
    Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria.
    Takuma Y; Takabatake H; Morimoto Y; Toshikuni N; Kayahara T; Makino Y; Yamamoto H
    Radiology; 2013 Dec; 269(3):927-37. PubMed ID: 24086071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resection or ablation versus transarterial therapy for Child-Pugh A patients with a single small hepatocellular carcinoma.
    Suh YJ; Jin YJ; Jeong Y; Shin WY; Lee JM; Cho S; Yu JH; Lee JW
    Medicine (Baltimore); 2021 Oct; 100(43):e27470. PubMed ID: 34713824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TACE combined Lenvatinib plus Camrelizumab versus TACE alone in efficacy and safety for unresectable hepatocellular carcinoma: a propensity score-matching study.
    Tang Z; Bai T; Wei T; Wang X; Chen J; Ye J; Li S; Wei M; Li X; Lin Y; Tang J; Li L; Wu F
    BMC Cancer; 2024 Jun; 24(1):717. PubMed ID: 38862932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined transarterial chemoembolization and thermal ablation in candidates to liver transplantation with hepatocellular carcinoma: pathological findings and post-transplant outcome.
    Fronda M; Susanna E; Doriguzzi Breatta A; Gazzera C; Patrono D; Piccione F; Bertero L; Ciferri F; Carucci P; Gaia S; Rolle E; Vocino Trucco G; Bergamasco L; Tandoi F; Cassoni P; Romagnoli R; Fonio P; Calandri M
    Radiol Med; 2024 Jul; 129(7):1086-1097. PubMed ID: 38829544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage.
    Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
    Saudi J Gastroenterol; 2018; 24(6):317-325. PubMed ID: 30117492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization combined with microwave ablation versus microwave ablation only for Barcelona clinic liver cancer Stage B hepatocellular carcinoma: A propensity score matching study.
    Li X; Chen B; An C; Cheng Z; Han Z; Liu F; Yu J; Liang P
    J Cancer Res Ther; 2020 Sep; 16(5):1027-1037. PubMed ID: 33004744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.